Five months after giving up on its lead drug Betalutin for follicular lymphoma, Nordic Nanovector has charted a course forward via a merger with fellow Norwegian biotech APIM Therapeutics. The merger ...
Rated 9.8 out of 10 in severity, the flaw could allow a remote attacker to gain unauthorized access to applications.
AI agents are the fastest-growing and least-governed class of these machine identities — and they don’t just authenticate, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback